Completed PHASE1 INTERVENTIONAL NCT00001737

Cyclosporin Implant to Treat Uveitis

A Pilot Study of a Sustained-Release Cyclosporine A Implant for Uveitis

Sponsor: National Eye Institute (NEI)

Conditions Eye Disease Inflammation Uveitis

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: May 31, 1998 Completion: Mar 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Eye Disease and Inflammation and is currently completed. National Eye Institute (NEI) leads this study, which shows 5 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States